Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: Results from the initial screening round of the IMPACT study.
Times cited: 119
Challenges to the development of new agents for molecularly defined patient subsets: Lessons from BRCA1/2-associated breast cancer.
Journal of Clinical Oncology.
Times cited: 16